Arvee Laboratories (India) Ltd.

ARVEE

INE006Z01016

Diversified Chemicals

Market Closed - NSE India S.E. Other stock markets 07:43:53 2024-06-26 EDT			5-day change	1st Jan Change
186.5 ^INR	-3.87%		-2.33%	+7.83%

05-17	Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
03-26	Arvee Laboratories Ltd. Announces Resignation of Mr. Dipen Dalal as Independent Director	CI

Arvee Laboratories India Ltd. Reports Earnings Results for the Half Year Ended September 30, 2019

November 13, 2019

Arvee Laboratories India Ltd. announced earnings results for the half year ended September 30, 2019. For the half year, the company announced total revenue was INR 269.821 million compared to INR 0 a year ago. Net income was INR 12.651 million compared to INR 0 a year ago. Basic earnings per share was INR 2.3 compared to INR 0 a year ago.

Latest news about Arvee Laboratories (India) Ltd.

Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-17	CI
Arvee Laboratories Ltd. Announces Resignation of Mr. Dipen Dalal as Independent Director	03-26	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-07	CI
Arvee Laboratories Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-05	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-11	CI
Arvee Laboratories Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-02	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-26	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-26	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-08	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Arvee Laboratories Ltd. Announces Demise of Parag Manubhai Shah, Independent Director	21-09-17	CI
Arvee Laboratories India Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2021	21-07-17	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-17	CI
1,130,000 Equity Shares of Arvee Laboratories Limited are subject to a Lock-Up Agreement Ending on 27-FEB-2021.	21-02-26	CI
Arvee Laboratories Ltd. Appoints Neetu Jalan as a Non-Executive Independent Director	21-02-12	CI
Arvee Laboratories Ltd. Announces Unaudited Earnings Results for the Half Year Ended September 30, 2020	20-12-07	CI
Arvee Laboratories India Ltd. Reports Earnings Results for the Full Year Ended March 31, 2020	20-06-29	CI
Arvee Laboratories Ltd. Approves Appointment of Mr. Paragbhai Manubhai Shah as Independent Director	20-06-27	CI
Arvee Laboratories India Ltd. Reports Earnings Results for the Half Year Ended September 30, 2019	19-11-13	CI
2,920,000 Equity Shares of Arvee Laboratories Limited are subject to a Lock-Up Agreement Ending on 27-FEB-2019.	19-02-26	CI
Arvee Laboratories Limited has completed an IPO in the amount of INR 89.06 million.	18-02-21	CI
Arvee Laboratories Limited has filed an IPO in the amount of INR 89.06 million.	17-12-21	CI

Chart Arvee Laboratories (India) Ltd.

Duration

Period

More charts

Company Profile

Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The Company's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.

Sector

Diversified Chemicals

Calendar

2024-07-29 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diversified Chemicals

	1st Jan change	Capi.
ARVEE LABORATORIES (INDIA) LTD.	+7.83%	25.62M
SHIN-ETSU CHEMICAL CO., LTD.	+5.07%	76.21B
BASF SE	-6.80%	44.33B
DUPONT DE NEMOURS, INC.	+4.59%	33.64B
PIDILITE INDUSTRIES LIMITED	+16.90%	19.13B
EASTMAN CHEMICAL COMPANY	+9.05%	11.52B
BRENNTAG SE	-23.22%	10.01B
SYENSQO SA/NV	-7.11%	10B
ASAHI KASEI CORPORATION	-1.35%	8.96B
SRF LIMITED	-3.15%	8.51B